Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Qualys (QLYS) Today — Nov 8, 2025: Analyst Upgrade Follows Q3 Beat; Guidance Raised as Stock Hovers Near $150

Qualys (QLYS) Today — Nov 8, 2025: Analyst Upgrade Follows Q3 Beat; Guidance Raised as Stock Hovers Near $150

Qualys, Inc. (NASDAQ: QLYS) is ending the week with fresh analyst attention after posting a stronger‑than‑expected third quarter and raising full‑year guidance earlier this week. As of today, one outlet reports an upgrade to Buy while another highlights lifted EPS
CAVA Stock News Today (Nov 8, 2025): Guidance Cut Fallout, Analyst Target Resets, and What’s Next for CAVA Group (NYSE: CAVA)

CAVA Stock News Today (Nov 8, 2025): Guidance Cut Fallout, Analyst Target Resets, and What’s Next for CAVA Group (NYSE: CAVA)

This week at a glance: why CAVA is in the headlines Analyst moves since the print These updates follow earlier, more bullish initiations earlier in the year, underscoring how quickly sentiment has cooled as traffic moderates. Investopedia+1 By the numbers
Sling TV adds 159,000 subscribers in Q3 2025 as $4.99 Day/Weekend/Week Passes and new $19.99 “Select” tier drive ~11% sequential growth

Sling TV adds 159,000 subscribers in Q3 2025 as $4.99 Day/Weekend/Week Passes and new $19.99 “Select” tier drive ~11% sequential growth

Why Sling is growing again Sling TV put points on the board in Q3 2025, logging approximately 159,000 net subscriber additions—a turnaround after earlier‑year declines. EchoStar’s Pay‑TV unit (DISH + Sling) closed the quarter with ~7.17 million customers, while the
8 November 2025
Pfizer (PFE) Clinches $10B Metsera Deal, Beating Novo Nordisk — What the Winning Bid Means for the Obesity-Drug Race (Nov. 8, 2025)

Pfizer (PFE) Clinches $10B Metsera Deal, Beating Novo Nordisk — What the Winning Bid Means for the Obesity-Drug Race (Nov. 8, 2025)

Pfizer Inc. (NYSE: PFE) has secured a definitive agreement to acquire weight‑loss biotech Metsera in a transaction valued at up to $10 billion, ending a high‑stakes bidding war with Novo Nordisk and positioning Pfizer squarely back in the fast‑growing obesity
Metsera (NASDAQ: MTSR): Pfizer Clinches $10B Deal as Novo Nordisk Bows Out — What to Know Today (Nov. 8, 2025)

Metsera (NASDAQ: MTSR): Pfizer Clinches $10B Deal as Novo Nordisk Bows Out — What to Know Today (Nov. 8, 2025)

Pfizer sealed a deal to acquire Metsera for up to $10 billion, ending one of 2025’s fiercest pharma bidding wars and reshaping the obesity‑drug race. Below are the facts, context, and what’s next for MTSR shareholders and the GLP‑1 landscape.
EOSE News Today (Nov 8, 2025): Analyst Downgrade Caps Volatile Week After Record Q3; Warrants Jump as New Orders Build

EOSE News Today (Nov 8, 2025): Analyst Downgrade Caps Volatile Week After Record Q3; Warrants Jump as New Orders Build

Eos Energy Enterprises, Inc. (NASDAQ: EOSE) closed out a whipsaw week with fresh weekend headlines: an analyst downgrade, a small fund trimming its position, and continued attention on the company’s Q3 results and growing long‑duration storage pipeline. Below is a
Today in Airline Routes (Nov. 8, 2025): Breeze enters Twin Falls; JetBlue targets Destin–Fort Walton; Spirit lands in Key West — plus key global moves

Today in Airline Routes (Nov. 8, 2025): Breeze enters Twin Falls; JetBlue targets Destin–Fort Walton; Spirit lands in Key West — plus key global moves

Breeze Airways is continuing its “underserved markets” strategy with a fresh round of growth for spring 2026 — and a brand‑new dot on its map: Twin Falls, Idaho (TWF). Starting March 6, 2026, Breeze will fly nonstop Twin Falls–Las Vegas
Conduent (CNDT) Q3 2025 Earnings: Revenue Misses at $767M as Adjusted EBITDA Margin Climbs to 5.2%; FY 2025 Margin Outlook 5.0%–5.5%, Shares Slide

Conduent (CNDT) Q3 2025 Earnings: Revenue Misses at $767M as Adjusted EBITDA Margin Climbs to 5.2%; FY 2025 Margin Outlook 5.0%–5.5%, Shares Slide

Conduent Incorporated (NASDAQ: CNDT) reported third‑quarter 2025 revenue of $767 million (down 5% YoY) and Adjusted EBITDA of $40 million with a 5.2% margin, reflecting continued cost discipline even as top‑line pressure persisted. Management reiterated a full‑year 2025 Adjusted EBITDA
Fluor (FLR) Q3 2025: Adjusted EPS Beats, Guidance Raised; $800M Buyback Target and NuScale Monetization Drive Outlook

Fluor (FLR) Q3 2025: Adjusted EPS Beats, Guidance Raised; $800M Buyback Target and NuScale Monetization Drive Outlook

What Fluor reported today Fluor Corporation released third‑quarter 2025 results before the market open. Headline items: Segment color. Strategy & capital allocation updates How the market is reacting today FLR traded sharply higher out of the gate before retracing; intraday
Franklin Resources (BEN) Q4 FY2025: Adj. EPS $0.67 Beats, Revenue $2.34B; AUM $1.66T as Ex‑Western Inflows Climb

Franklin Resources (BEN) Q4 FY2025: Adj. EPS $0.67 Beats, Revenue $2.34B; AUM $1.66T as Ex‑Western Inflows Climb

Franklin Resources, Inc. (NYSE: BEN), the parent of Franklin Templeton, reported preliminary fiscal Q4 2025 results before the bell Friday, posting GAAP revenue of $2.34 billion and adjusted diluted EPS of $0.67, topping pre‑earnings consensus that had centered around $0.57
1 62 63 64 65 66 232
Go toTop